Inflammatory Bowel Disease Center, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
© Copyright 2017. Korean Association for the Study of Intestinal Diseases.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Author (year) | No. of patients | Anastomotic stricture (%) | Maximum dilation diameter (mm) | Scope passing (%) | Technical response (%) | Clinical responsea (%) | Perforation (%) | Observation period (mo) | Symptom recurrence (%) |
---|---|---|---|---|---|---|---|---|---|
Blomberg et al. (1991)8 | 27 | 100 | 25 | 100 | 100 | 67 | 7 | 19 | 33 |
Couckuyt et al. (1995)9 | 55 | 62 | 20 | 73 | 85 | 60 | 11 | 34 | 62 |
Matsui et al. (2000)10 | 31 | 31 | 25 | NA | 86 | 86 | 2 | 37 | 55 |
Sabaté et al. (2003)11 | 38 | 68 | 25 | 56 | 84 | 53 | 9 | 60 | 63 |
Thomas-Gibson et al. (2003)12 | 59 | 90 | 18 | 74 | 81 | NA | 2 | 29 | 41 |
Morini et al. (2003)13 | 43 | 67 | 18 | 70 | 79 | 42 | 0 | NA | NA |
Singh et al. (2005)14 | 17 | 41 | 20 | 96 | 100 | 76 | 10 | 18 | 76 |
Nomura et al. (2006)15 | 16 | 44 | 20 | 94 | 94 | 81 | 6 | 20 | 69 |
Ferlitsch et al. (2006)16 | 46 | 59 | 20 | NA | 85 | 57 | 4 | 21 | 62 |
Thienpont et al. (2010)17 | 138 | 84 | 18 | 97 | 97 | 76 | 4 | 70 | 56 |
Mueller et al. (2010)18 | 55 | 23 | 18 | 95 | 95 | 76 | 2 | 44 | 24 |
Scimeca et al. (2011)19 | 37 | 90 | 20 | NA | 84 | 89 | 0 | 26 | 76 |
Gustavsson et al. (2012)20 | 178 | 80 | 25 | NA | 89 | 77 | 6 | 84b | NA |
Nanda et al. (2013)21 | 31 | 74 | 18 | 100 | 100 | 90 | 0 | 46 | 79 |
Endo et al. (2013)22 | 30 | 36 | 20 | 94 | 94 | NA | 7 | 26 | NA |
Bhalme et al. (2014)23 | 79 | 57 | 20 | 96 | 96 | NA | 0 | 27 | 63 |
Atreja et al. (2014)24 | 128 | 48 | 20 | 83 | 83 | NA | 2 | 33 | NA |
Author (year) | No. of CD patients | Maximum dilation diameter (mm) | Technical success (%) | Clinical efficacya (%) | Perforation (%) | Observation period (mo) | Symptom recurrence (%) |
---|---|---|---|---|---|---|---|
Fukumoto et al. (2007)27 | 23 | NA | NA | 74b | 0 | 12 | 26b |
Pohl et al. (2007)28 | 10 | 16.5 | NA | 80 | 0 | NA | NA |
Ohmiya et al. (2009)29 | 16 | 20 | 96 | NA | NA | NA | 31b |
Despott et al. (2009)30 | 11 | 20 | 73 | 73 | 9 | 21 | 25 |
Hirai et al. (2010)31 | 25 | 18 | 72 | 72 | 0 | 11 | 22 |
Gill and Kaffes (2014)32 | 10 | 16.5 | 100 | 80 | 20 | NA | NA |
Hirai et al. (2014)33 | 65 | 20 | 80 | 80 | 2 | 40 | 37 |
Sunada et al. (2016)34 | 85 | 15 | NA | 87 | 5 | 42 | NA |
Author (year) | No. of patients | Anastomotic stricture (%) | Maximum dilation diameter (mm) | Scope passing (%) | Technical response (%) | Clinical responsea (%) | Perforation (%) | Observation period (mo) | Symptom recurrence (%) |
---|---|---|---|---|---|---|---|---|---|
Blomberg et al. (1991) | 27 | 100 | 25 | 100 | 100 | 67 | 7 | 19 | 33 |
Couckuyt et al. (1995) | 55 | 62 | 20 | 73 | 85 | 60 | 11 | 34 | 62 |
Matsui et al. (2000) | 31 | 31 | 25 | NA | 86 | 86 | 2 | 37 | 55 |
Sabaté et al. (2003) | 38 | 68 | 25 | 56 | 84 | 53 | 9 | 60 | 63 |
Thomas-Gibson et al. (2003) | 59 | 90 | 18 | 74 | 81 | NA | 2 | 29 | 41 |
Morini et al. (2003) | 43 | 67 | 18 | 70 | 79 | 42 | 0 | NA | NA |
Singh et al. (2005) | 17 | 41 | 20 | 96 | 100 | 76 | 10 | 18 | 76 |
Nomura et al. (2006) | 16 | 44 | 20 | 94 | 94 | 81 | 6 | 20 | 69 |
Ferlitsch et al. (2006) | 46 | 59 | 20 | NA | 85 | 57 | 4 | 21 | 62 |
Thienpont et al. (2010) | 138 | 84 | 18 | 97 | 97 | 76 | 4 | 70 | 56 |
Mueller et al. (2010) | 55 | 23 | 18 | 95 | 95 | 76 | 2 | 44 | 24 |
Scimeca et al. (2011) | 37 | 90 | 20 | NA | 84 | 89 | 0 | 26 | 76 |
Gustavsson et al. (2012) | 178 | 80 | 25 | NA | 89 | 77 | 6 | 84b | NA |
Nanda et al. (2013) | 31 | 74 | 18 | 100 | 100 | 90 | 0 | 46 | 79 |
Endo et al. (2013) | 30 | 36 | 20 | 94 | 94 | NA | 7 | 26 | NA |
Bhalme et al. (2014) | 79 | 57 | 20 | 96 | 96 | NA | 0 | 27 | 63 |
Atreja et al. (2014) | 128 | 48 | 20 | 83 | 83 | NA | 2 | 33 | NA |
aAccording to definition based on each study.
bAvailable only in patients from the primary catchment area.
NA, not available.
Author (year) | No. of CD patients | Maximum dilation diameter (mm) | Technical success (%) | Clinical efficacya (%) | Perforation (%) | Observation period (mo) | Symptom recurrence (%) |
---|---|---|---|---|---|---|---|
Fukumoto et al. (2007) | 23 | NA | NA | 74b | 0 | 12 | 26b |
Pohl et al. (2007) | 10 | 16.5 | NA | 80 | 0 | NA | NA |
Ohmiya et al. (2009) | 16 | 20 | 96 | NA | NA | NA | 31b |
Despott et al. (2009) | 11 | 20 | 73 | 73 | 9 | 21 | 25 |
Hirai et al. (2010) | 25 | 18 | 72 | 72 | 0 | 11 | 22 |
Gill and Kaffes (2014) | 10 | 16.5 | 100 | 80 | 20 | NA | NA |
Hirai et al. (2014) | 65 | 20 | 80 | 80 | 2 | 40 | 37 |
Sunada et al. (2016) | 85 | 15 | NA | 87 | 5 | 42 | NA |
aAccording to definition based on each study.
bData from patients with CD only.
NA, not available.
aAccording to definition based on each study. bAvailable only in patients from the primary catchment area. NA, not available.
aAccording to definition based on each study. bData from patients with CD only. NA, not available.